InCephalo Therapeutics
PrivateLast Round
Grant
Aug 22, 2022
Total Funding Raised
$2.96M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
InCephalo Therapeutics operates in Healthcare & Life Sciences and is based in Basel. Its latest recorded funding round was a Grant round in August 2022.
InCephalo Therapeutics is a pharmaceuticals and biotechnology company that develops novel therapies for the treatment of brain cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InCephalo Therapeutics Comparables
Compare InCephalo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Siren Biotechnology | 79% | |
| Precision NeuroMed | 77% | |
| Trogenix | 72% |
For institutional investors. Book with your work email.
InCephalo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 22, 2022 | ||||
| Accelerator | Jun 28, 2021 |
For institutional investors. Book with your work email.
InCephalo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EIT Health | Grant |
| Eurostars SME programme | Grant |
| Swiss State Secretariat for Education, Research and Innovation (SERI) | Grant |
| BaseLaunch | Accelerator |
| University of Basel | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 677% MoM.
- May 2, 2025
Monthly visitors increased 1133% MoM, from 78 to 962.
For institutional investors. Book with your work email.
InCephalo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about InCephalo Therapeutics's valuation, stock price, and market status.
Is InCephalo Therapeutics a public or private company?
InCephalo Therapeutics is a private company.
What is the current stock price of InCephalo Therapeutics?
InCephalo Therapeutics is a private company, so its shares have no public market price. Caplight tracks InCephalo Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is InCephalo Therapeutics worth (valuation)?
Valuation information for InCephalo Therapeutics is not publicly available.
Can I buy InCephalo Therapeutics stock?
InCephalo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was InCephalo Therapeutics's last funding round?
InCephalo Therapeutics's most recent funding round was Grant on August 22, 2022.
Who are the main investors in InCephalo Therapeutics?
Key investors in InCephalo Therapeutics include BaseLaunch.
Will InCephalo Therapeutics IPO soon?
No public IPO plans have been announced for InCephalo Therapeutics.
How can I track InCephalo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in InCephalo Therapeutics's shares on secondary markets.